title: Evolving role of cardiopulmonary exercise testing in cardiovascular disease.
abstract: CPX testing allows for the objective assessment of aerobic capacity, anaerobic threshold, and the ventilatory response to exercise in patients with cardiovascular disease. These results can be used to assess severity of disease, its progression over time, prognosis, candidacy for transplantation, and response to therapy. CPX testing can also serve to distinguish cardiac from ventilatory causes of exertional dyspnea.
authors.affiliation: Department of Internal Medicine, University of Missouri Health Sciences Center, Columbia.
authors.forename: I E
authors.initials: IE
authors.lastname: Tjahja
authors.forename: H K
authors.initials: HK
authors.lastname: Reddy
authors.forename: J S
authors.initials: JS
authors.lastname: Janicki
authors.forename: K T
authors.initials: KT
authors.lastname: Weber
mesh_terms: D015308:Anaerobic Threshold; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D005080:Exercise Test; D017079:Exercise Tolerance; D006339:Heart Rate; D006801:Humans; D010092:Oximetry; D010101:Oxygen Consumption; D011379:Prognosis; D012120:Respiration Disorders / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D012720:Severity of Illness Index